Naveen Pemmaraju/mdanderson.org
Oct 14, 2024, 15:52
Ashwin Kishtagari: Naveen Pemmaraju explores the potential of novel JAK inhibitors in myelofibrosis
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared on X:
” Naveen Pemmaraju explores the potential of novel JAK inhibitors in myelofibrosis at the 2024 Summit on Hematological Cancers in Nashville: Are we on the brink of redefining treatment strategies and improving patient outcomes?”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 27, 2025, 18:37
Jan 27, 2025, 18:35
Jan 27, 2025, 18:25
Jan 27, 2025, 18:15
Jan 27, 2025, 18:11
Jan 27, 2025, 18:09
Jan 27, 2025, 17:49